The IL2-sEVs promoted CD8+ T cell-mediated cytotoxicity in a melanoma model and effectively inhibited tumor growth and metastasis by a 4-fold reduction compared to the untreated control group [207]. The gene discussed is CD8A; the disease is melanoma.